Wei Zuo Selected Research

IMM-H004

10/2017	IMM-H004, A New Coumarin Derivative, Improved Focal Cerebral Ischemia via Blood-Brain Barrier Protection in Rats.
1/2017	Upregulating the Expression of Survivin-HBXIP Complex Contributes to the Protective Role of IMM-H004 in Transient Global Cerebral Ischemia/Reperfusion.
4/2016	A new coumarin derivative, IMM-H004, attenuates okadaic acid-induced spatial memory impairment in rats.
3/2015	Compound IMM-H004, a novel coumarin derivative, protects against CA1 cell loss and spatial learning impairments resulting from transient global ischemia.
6/2014	IMM-H004 prevents toxicity induced by delayed treatment of tPA in a rat model of focal cerebral ischemia involving PKA-and PI3K-dependent Akt activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wei Zuo Research Topics

Disease

14	Neoplasms (Cancer) 01/2022 - 08/2014
9	Brain Ischemia (Cerebral Ischemia) 01/2022 - 06/2013
8	Infections 05/2022 - 01/2015
7	Inflammation (Inflammations) 10/2022 - 12/2011
6	Ischemia 10/2020 - 05/2014
5	Stroke (Strokes) 08/2020 - 06/2013
5	Osteonecrosis (Kienbock's Disease) 04/2020 - 01/2016
4	Ischemic Stroke 01/2016 - 05/2014
3	Non-alcoholic Fatty Liver Disease 10/2022 - 01/2022
3	Carcinogenesis 11/2021 - 01/2016
3	COVID-19 01/2021 - 12/2020
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 07/2019
3	Necrosis 01/2021 - 01/2016
3	Aplastic Anemia (Anemia, Hypoplastic) 01/2021 - 01/2020
3	Lung Neoplasms (Lung Cancer) 01/2021 - 04/2019
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2016 - 06/2014
2	Fibrosis (Cirrhosis) 10/2022 - 01/2019
2	Atrial Fibrillation 01/2022 - 09/2020
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 09/2016
2	Hemorrhage 01/2022 - 12/2019
2	Alcoholism (Alcohol Abuse) 01/2022 - 01/2017
2	Chronic Obstructive Pulmonary Disease (COPD) 06/2021 - 01/2015
2	Infarction (Infarctions) 01/2021 - 06/2014
2	Brain Infarction 01/2021 - 01/2016
2	Reperfusion Injury 01/2021 - 01/2016
2	Brain Injuries (Brain Injury) 01/2021 - 07/2013
2	Edema (Dropsy) 08/2020 - 10/2017
2	Cerebral Infarction 08/2020 - 10/2017
2	Hyperglycemia 01/2019 - 05/2014
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2019 - 01/2015
2	Arthritis (Polyarthritis) 12/2018 - 12/2011
2	Mitochondrial Diseases (Mitochondrial Disease) 12/2017 - 10/2017
2	Prostatic Neoplasms (Prostate Cancer) 01/2017 - 01/2003
2	Osteoarthritis 01/2015 - 12/2011
2	Lymphoma (Lymphomas) 12/2014 - 02/2013
1	Liver Cirrhosis (Hepatic Cirrhosis) 07/2022
1	Gastritis 05/2022
1	Colorectal Neoplasms (Colorectal Cancer) 02/2022
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	Sepsis (Septicemia) 01/2022
1	Erythema 01/2022
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2022
1	Coma (Comas) 01/2022
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2022
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022
1	Neuroblastoma 01/2022

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 10/2022 - 08/2010
5	Pharmaceutical PreparationsIBA 01/2022 - 12/2011
5	IMM-H004IBA 10/2017 - 06/2014
4	CytokinesIBA 01/2021 - 07/2013
3	LipidsIBA 10/2022 - 01/2022
3	CateninsIBA 05/2022 - 09/2014
3	LipopolysaccharidesIBA 02/2022 - 01/2021
3	GlucocorticoidsIBA 07/2021 - 11/2019
3	Biological ProductsIBA 01/2021 - 07/2013
3	Oxygen (Dioxygen)IBA 01/2021 - 11/2014
3	eltrombopag FDA Link 01/2021 - 01/2020
3	AntioxidantsIBA 12/2017 - 03/2015
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2022 - 12/2011
2	Bleomycin (Blenoxane)FDA LinkGeneric 07/2021 - 01/2019
2	CalciumIBA 03/2021 - 11/2016
2	Vitamin D FDA LinkGeneric 01/2021 - 11/2016
2	triphenyltetrazoliumIBA 01/2021 - 01/2016
2	MicroRNAs (MicroRNA)IBA 08/2020 - 07/2019
2	Opioid Analgesics (Opioids)IBA 04/2020 - 04/2019
2	CoumarinsIBA 10/2017 - 03/2015
2	coumarinIBA 01/2017 - 03/2015
2	ArtesunateIBA 01/2017 - 08/2014
2	Glucose (Dextrose)FDA LinkGeneric 11/2014 - 05/2014
2	Dinoprostone (PGE2)FDA Link 08/2014 - 12/2011
1	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2022
1	Apolipoproteins E (ApoE)IBA 07/2022
1	Receptor for Advanced Glycation End ProductsIBA 07/2022
1	Transcription Factors (Transcription Factor)IBA 05/2022
1	Sirtuin 1IBA 02/2022
1	Volatile Fatty AcidsIBA 02/2022
1	CCAAT-Enhancer-Binding Protein-betaIBA 02/2022
1	Dual Specificity Phosphatase 6IBA 02/2022
1	LuciferasesIBA 02/2022
1	betrixabanIBA 01/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2022
1	Urea (Carbamide)FDA LinkGeneric 01/2022
1	AnticoagulantsIBA 01/2022
1	Clopidogrel (Plavix)FDA Link 01/2022
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2022
1	apixabanIBA 01/2022
1	CreatinineIBA 01/2022
1	RivaroxabanIBA 01/2022

Therapy/Procedure

11	Therapeutics 01/2022 - 06/2013
5	Transplantation 01/2022 - 01/2018
3	Knee Replacement Arthroplasty (Total Knee Replacement) 04/2019 - 01/2015
3	Bone Transplantation (Bone Grafting) 04/2016 - 01/2016
2	Hematopoietic Stem Cell Transplantation 01/2022 - 01/2021
2	Stem Cell Transplantation 06/2021 - 01/2020
2	Aftercare (After-Treatment) 06/2021 - 06/2020
2	Prostheses and Implants (Prosthesis) 02/2020 - 01/2020
2	Drug Therapy (Chemotherapy) 01/2019 - 10/2017
1	Radiotherapy 02/2022
1	Artificial Respiration (Mechanical Ventilation) 01/2022
1	Neoadjuvant Therapy 01/2022